Literature DB >> 6126896

Induction of dopaminergic supersensitivity after a single dose of the neuroleptic isofloxythepin.

M Valchár, J Metysová, J Chlebounová, A Dlabac.   

Abstract

The development of dopaminergic supersensitivity was evaluated, after single oral administration of the long-acting neuroleptic drug isofloxythepin, in nigrostriatal and tuberoinfundibular system in the rat. Isofloxythepin (5 mg/kg orally) increased concentration homovanillic acid (HVA) in the striatum for up to 24 h after administration, whereas a significant decrease below control values was found after 4-5 days. A similar biphasic effect appeared in behavior, since there was an enhancement of apomorphine stereotypy 4-5 days after administration of isofloxythepin (5 and 10 mg/kg orally). Both findings agree with the hypothesis of development of nigrostriatal dopaminergic supersensitivity at long intervals after isofloxythepin. On the other hand, the increase in prolactin (PRL) secretion induced by isofloxythepin indicated only the blocking action of this drug on dopamine receptors in the tuberoinfundibular system, and provided no evidence for tuberoinfundibular dopaminergic supersensitivity after neuroleptic treatment. It is concluded that a single dose of isofloxythepin is capable of inducing dopaminergic supersensitivity in the nigrostriatal system, but not in the tuberoinfundibular system.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6126896     DOI: 10.1007/bf00449129

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  25 in total

1.  Long-term effects of teflutixol on the synthesis and endogenous levels of mouse brain catecholamines.

Authors:  J Hyttel
Journal:  J Neurochem       Date:  1975-11       Impact factor: 5.372

2.  No evidence for increased dopamine receptor binding in superresponsive mice after a single dose of neuroleptics.

Authors:  J Hyttel
Journal:  Adv Biochem Psychopharmacol       Date:  1980

3.  Effect of single and repeated administration of clozapine on the metabolism of dopamine and noradrenaline in the brain of the rat.

Authors:  H R Bürki; W Ruch; H Asper; M Baggiolini; G Stille
Journal:  Eur J Pharmacol       Date:  1974-07       Impact factor: 4.432

4.  Novel information about the influence of fluorination on activity in a series of tricyclic neuroleptic agents.

Authors:  M Protiva; J Metysová
Journal:  Act Nerv Super (Praha)       Date:  1978-12

5.  Regional rat brain levels of 3,4-dihydroxyphenylacetic acid and homovanillic acid: concurrent fluorometric measurement and influence of drugs.

Authors:  B H Westerink; J Korf
Journal:  Eur J Pharmacol       Date:  1976-08       Impact factor: 4.432

6.  Clozapine: reduction of the initial dopamine turnover increase by repeated treatment.

Authors:  P C Waldmeier; L Maître
Journal:  Eur J Pharmacol       Date:  1976-07       Impact factor: 4.432

7.  Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazine.

Authors:  A C Sayers; H R Bürki; W Ruch; H Asper
Journal:  Psychopharmacologia       Date:  1975

8.  Enhancement of dopamine-stimulated adenylate cyclase activity in rat caudate after lesions in substantia nigra: evidence for denervation supersensitivity.

Authors:  R K Mishra; E L Gardner; R Katzman; M H Makman
Journal:  Proc Natl Acad Sci U S A       Date:  1974-10       Impact factor: 11.205

9.  Differential effects of acute and chronic haloperidol treatment on striatal and nigral 3,4-dihydroxyphenylacetic acid (DOPAC) levels.

Authors:  E Meller; A J Friedhoff; E Friedman
Journal:  Life Sci       Date:  1980-02-18       Impact factor: 5.037

10.  Comparative effects of penfluridol on circling behavior and striatal DOPAC and serum prolactin concentrations in the rat.

Authors:  L A Annunziato; S M Wuerthele; K E Moore
Journal:  Eur J Pharmacol       Date:  1978-08-01       Impact factor: 4.432

View more
  2 in total

1.  Neuroendocrine effects of clonidine in chronic schizophrenic patients under long-term neuroleptic therapy and after drug withdrawal: relations to psychopathology.

Authors:  F Müller-Spahn; M Ackenheil; M Albus; C Botschev; D Naber; D Welter
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Neuroendocrine effects of apomorphine in chronic schizophrenic patients under long-term neuroleptic therapy and after drug withdrawal: relations to psychopathology and tardive dyskinesia.

Authors:  F Müller-Spahn; M Ackenheil; M Albus; G May; D Naber; D Welter; K Zander
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.